Our data illustrated that the inhibition of atypical PKC in CRC cells reduced the level of ARP2 in treated cancerous cells compared to both healthy colon cells and untreated cancerous cells (Figure 7(a,b)). Here, PRRT2 is linked to colorectal carcinoma.